These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15869351)

  • 1. Delta plots in the study of individual differences: new tools reveal response inhibition deficits in AD/Hd that are eliminated by methylphenidate treatment.
    Ridderinkhof KR; Scheres A; Oosterlaan J; Sergeant JA
    J Abnorm Psychol; 2005 May; 114(2):197-215. PubMed ID: 15869351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptual and response interference in children with attention-deficit hyperactivity disorder, and the effects of methylphenidate.
    Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Kenemans JL; Camfferman G; Buitelaar JK; Koelega HS
    Psychophysiology; 1999 Jul; 36(4):419-29. PubMed ID: 10432791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of methylphenidate on response inhibition and the event-related potential of children with attention deficit/hyperactivity disorder.
    Broyd SJ; Johnstone SJ; Barry RJ; Clarke AR; McCarthy R; Selikowitz M; Lawrence CA
    Int J Psychophysiol; 2005 Oct; 58(1):47-58. PubMed ID: 15925419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.
    Turner DC; Clark L; Dowson J; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2004 May; 55(10):1031-40. PubMed ID: 15121488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder.
    O'Driscoll GA; Dépatie L; Holahan AL; Savion-Lemieux T; Barr RG; Jolicoeur C; Douglas VI
    Biol Psychiatry; 2005 Jun; 57(11):1452-60. PubMed ID: 15950020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
    Huang YS; Chao CC; Wu YY; Chen YY; Chen CK
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate effects on task-switching performance in attention-deficit/hyperactivity disorder.
    Kramer AF; Cepeda NJ; Cepeda ML
    J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1277-84. PubMed ID: 11699801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.
    Navarra R; Graf R; Huang Y; Logue S; Comery T; Hughes Z; Day M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):34-41. PubMed ID: 17714843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD.
    Johnson KA; Barry E; Bellgrove MA; Cox M; Kelly SP; Dáibhis A; Daly M; Keavey M; Watchorn A; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Gill M
    Neuropsychologia; 2008 Apr; 46(5):1532-41. PubMed ID: 18289615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder.
    Langleben DD; Monterosso J; Elman I; Ash B; Krikorian G; Austin G
    Psychiatry Res; 2006 Mar; 141(3):315-20. PubMed ID: 16516306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine motor skills and effects of methylphenidate in children with attention-deficit-hyperactivity disorder and developmental coordination disorder.
    Flapper BC; Houwen S; Schoemaker MM
    Dev Med Child Neurol; 2006 Mar; 48(3):165-9. PubMed ID: 16483390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methylphenidate on EEG coherence in attention-deficit/hyperactivity disorder.
    Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Johnstone SJ; Abbott I; Croft RJ; Magee CA; Hsu CI; Lawrence CA
    Int J Psychophysiol; 2005 Oct; 58(1):4-11. PubMed ID: 15921774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
    Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
    Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of methylphenidate on postural stability under single and dual task conditions in children with attention deficit hyperactivity disorder - a double blind randomized control trial.
    Jacobi-Polishook T; Shorer Z; Melzer I
    J Neurol Sci; 2009 May; 280(1-2):15-21. PubMed ID: 19217632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise impact on sustained attention of ADHD children, methylphenidate effects.
    Medina JA; Netto TL; Muszkat M; Medina AC; Botter D; Orbetelli R; Scaramuzza LF; Sinnes EG; Vilela M; Miranda MC
    Atten Defic Hyperact Disord; 2010 Mar; 2(1):49-58. PubMed ID: 21432590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prepotent response inhibition predicts treatment outcome in attention deficit/hyperactivity disorder.
    van der Oord S; Geurts HM; Prins PJ; Emmelkamp PM; Oosterlaan J
    Child Neuropsychol; 2012; 18(1):50-61. PubMed ID: 21819279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.